You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: September 24, 2023

Cipla Ltd Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CIPLA LTD, and what generic and branded alternatives to CIPLA LTD drugs are available?

CIPLA LTD has ten approved drugs.

There are nine tentative approvals on CIPLA LTD drugs.

Summary for Cipla Ltd

US Patents:	0
Tradenames:	9
Ingredients:	9
NDAs:	10
Drug Master File Entries:	217
PTAB Cases with Cipla Ltd as petitioner:	See PTAB cases with Cipla Ltd as petitioner

Drugs and US Patents for Cipla Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cipla Ltd	ZIDOVUDINE	zidovudine	SOLUTION;ORAL	077981-001	Jun 26, 2008	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Cipla Ltd	IRINOTECAN HYDROCHLORIDE	irinotecan hydrochloride	INJECTABLE;INJECTION	077219-001	Feb 20, 2008		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Cipla Ltd	TOPIRAMATE	topiramate	TABLET;ORAL	076343-003	Mar 27, 2009	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Cipla Ltd	DONEPEZIL HYDROCHLORIDE	donepezil hydrochloride	TABLET;ORAL	077518-001	May 31, 2011	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Cipla Ltd	STAVUDINE	stavudine	FOR SOLUTION;ORAL	078030-001	Mar 20, 2009		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Cipla Ltd	CARBOPLATIN	carboplatin	INJECTABLE;INJECTION	077383-002	Jan 27, 2006		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Cipla Ltd	CETIRIZINE HYDROCHLORIDE ALLERGY	cetirizine hydrochloride	TABLET;ORAL	077318-001	Jul 25, 2013		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Dow

Medtronic

Boehringer Ingelheim

Express Scripts

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.